Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy

The Journal of Pharmacology and Experimental Therapeutics
Rui JuCaiying Ye

Abstract

The anticancer and anti-inflammatory effects of carboxyamidotriazole (CAI) have been demonstrated in several studies, but the underlying mechanisms remain to be elucidated. This study showed that CAI caused metabolic reprogramming of pancreatic cancer cells. The inhibition of mitochondrial oxidative metabolism by CAI led to increased glutamine-dependent reductive carboxylation and enhanced glycolytic metabolism. The presence of environmental substances that affect cellular metabolism, such as glutamine and pyruvate, attenuated the anticancer efficacy of CAI. Based on the action of CAI: 1) when glutamine was removed, the NAD+/NADH ratio was decreased, the synthesis of cellular aspartate was reduced, and autophagy flux was blocked; and 2) when glycolysis was pharmacologically inhibited, the ATP level was significantly decreased, the cell viability was greatly inhibited, and the compensatory rescue effect of glutamine was eliminated. When combined with chemotherapy, cotreatment with CAI and the glycolysis inhibitor 2-deoxyglucose (2-DG) inhibited the pancreatic cancer progression after chemotherapy. As the inhibition of mitochondrial oxidative metabolism can explain several anticancer activities of CAI reported previously, includi...Continue Reading

References

Jan 15, 1972·International Journal of Cancer. Journal International Du Cancer·S C BansalH O Sjögren
Oct 9, 1996·International Journal of Cancer. Journal International Du Cancer·W J WasilenkoP F Schellhammer
Jan 1, 1996·Investigational New Drugs·D S Shewach, T S Lawrence
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LouvetUNKNOWN GISCAD
Nov 22, 2011·Nature·Andrew R MullenRalph J DeBerardinis
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
Dec 18, 2014·Nature Chemical Biology·Samuel E Weinberg, Navdeep S Chandel
Jul 1, 2015·Proceedings of the National Academy of Sciences of the United States of America·M Cecilia CainoDario C Altieri
Aug 25, 2015·Cell Metabolism·Francesc BaixauliMaria Mittelbrunn
Sep 17, 2015·Cancer Research·Andrea VialeGiulio F Draetta
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Dec 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jianhai DuJennifer R Chao
May 16, 2017·Nature Cell Biology·Elena AnsóNavdeep S Chandel
Jan 13, 2018·Nature·Véronique FrattiniAntonio Iavarone

❮ Previous
Next ❯

Citations

Oct 27, 2020·Journal of Medicinal Chemistry·Yibin XuNouri Neamati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.